High Level of Tobacco Carcinogen–Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers

Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of oral/head and neck squamous cell cancer (HNSCC). We recently reported higher levels of TSNA-associated DNA adducts in the oral cells of smokers wi...

Full description

Saved in:
Bibliographic Details
Published inCancer prevention research (Philadelphia, Pa.) Vol. 10; no. 9; pp. 507 - 513
Main Authors Khariwala, Samir S., Ma, Bin, Ruszczak, Chris, Carmella, Steven G., Lindgren, Bruce, Hatsukami, Dorothy K., Hecht, Stephen S., Stepanov, Irina
Format Journal Article
LanguageEnglish
Published United States 01.09.2017
Subjects
Online AccessGet full text
ISSN1940-6207
1940-6215
1940-6215
DOI10.1158/1940-6207.CAPR-17-0140

Cover

Loading…
Abstract Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of oral/head and neck squamous cell cancer (HNSCC). We recently reported higher levels of TSNA-associated DNA adducts in the oral cells of smokers with HNSCC as compared with cancer-free smokers. In this study, we further investigated the tobacco constituent exposures in the same smokers to better understand the potential causes for the elevated oral DNA damage in smokers with HNSCC. Subjects included cigarette smokers with HNSCC (cases, n = 30) and cancer-free smokers (controls, n = 35). At recruitment, tobacco/alcohol use questionnaires were completed, and urine and oral cell samples were obtained. Analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and N'-Nitrosonornicotine (NNN; TSNA biomarkers), 1-hydroxypyrene (1-HOP, a PAH), cotinine, 3′-hydroxycotinine, and the nicotine metabolite ratio (NMR) were performed. Cases and controls differed in mean age, male preponderance, and frequency of alcohol consumption (but not total alcoholic drinks). Univariate analysis revealed similar levels of NNN, 1-HOP, and cotinine between groups but, as reported previously, significantly higher DNA adduct formation in the cases. Multiple regression adjusting for potential confounders showed persistent significant difference in DNA adduct levels between cases and controls [ratio of geometric means, 20.0; 95% CI, 2.7–148.6). Our cohort of smokers with HNSCC demonstrates higher levels of TSNA-derived oral DNA damage in the setting of similar exposure to nicotine and tobacco carcinogens. Among smokers, DNA adduct formation may act as a predictor of eventual development of HNSCC that is independent of carcinogen exposure indicators. Cancer Prev Res; 10(9); 507–13. ©2017 AACR. See related editorial by Johnson and Bauman, p. 489
AbstractList Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of oral/head and neck squamous cell cancer (HNSCC). We recently reported higher levels of TSNA-associated DNA adducts in the oral cells of smokers with HNSCC as compared with cancer-free smokers. In this study, we further investigated the tobacco constituent exposures in the same smokers to better understand the potential causes for the elevated oral DNA damage in smokers with HNSCC. Subjects included cigarette smokers with HNSCC (cases, n = 30) and cancer-free smokers (controls, n = 35). At recruitment, tobacco/alcohol use questionnaires were completed, and urine and oral cell samples were obtained. Analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and N'-Nitrosonornicotine (NNN; TSNA biomarkers), 1-hydroxypyrene (1-HOP, a PAH), cotinine, 3′-hydroxycotinine, and the nicotine metabolite ratio (NMR) were performed. Cases and controls differed in mean age, male preponderance, and frequency of alcohol consumption (but not total alcoholic drinks). Univariate analysis revealed similar levels of NNN, 1-HOP, and cotinine between groups but, as reported previously, significantly higher DNA adduct formation in the cases. Multiple regression adjusting for potential confounders showed persistent significant difference in DNA adduct levels between cases and controls [ratio of geometric means, 20.0; 95% CI, 2.7–148.6). Our cohort of smokers with HNSCC demonstrates higher levels of TSNA-derived oral DNA damage in the setting of similar exposure to nicotine and tobacco carcinogens. Among smokers, DNA adduct formation may act as a predictor of eventual development of HNSCC that is independent of carcinogen exposure indicators. Cancer Prev Res; 10(9); 507–13. ©2017 AACR. See related editorial by Johnson and Bauman, p. 489
Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of oral/head and neck squamous cell cancer (HNSCC). We recently reported higher levels of TSNA-associated DNA adducts in the oral cells of smokers with HNSCC as compared with cancer-free smokers. In this study, we further investigated the tobacco constituent exposures in the same smokers to better understand the potential causes for the elevated oral DNA damage in smokers with HNSCC. Subjects included cigarette smokers with HNSCC (cases, n = 30) and cancer-free smokers (controls, n = 35). At recruitment, tobacco/alcohol use questionnaires were completed, and urine and oral cell samples were obtained. Analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and N '-Nitrosonornicotine (NNN; TSNA biomarkers), 1-hydroxypyrene (1-HOP, a PAH), cotinine, 3′-hydroxycotinine, and the nicotine metabolite ratio (NMR) were performed. Cases and controls differed in mean age, male preponderance, and frequency of alcohol consumption (but not total alcoholic drinks). Univariate analysis revealed similar levels of NNN, 1-HOP, and cotinine between groups but, as reported previously, significantly higher DNA adduct formation in the cases. Multiple regression adjusting for potential confounders showed persistent significant difference in DNA adduct levels between cases and controls [ratio of geometric means, 20.0; 95% CI, 2.7–148.6). Our cohort of smokers with HNSCC demonstrates higher levels of TSNA-derived oral DNA damage in the setting of similar exposure to nicotine and tobacco carcinogens. Among smokers, DNA adduct formation may act as a predictor of eventual development of HNSCC that is independent of carcinogen exposure indicators.
Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of oral/head and neck squamous cell cancer (HNSCC). We recently reported higher levels of TSNA-associated DNA adducts in the oral cells of smokers with HNSCC as compared with cancer-free smokers. In this study, we further investigated the tobacco constituent exposures in the same smokers to better understand the potential causes for the elevated oral DNA damage in smokers with HNSCC. Subjects included cigarette smokers with HNSCC (cases, n = 30) and cancer-free smokers (controls, n = 35). At recruitment, tobacco/alcohol use questionnaires were completed, and urine and oral cell samples were obtained. Analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and N'-Nitrosonornicotine (NNN; TSNA biomarkers), 1-hydroxypyrene (1-HOP, a PAH), cotinine, 3'-hydroxycotinine, and the nicotine metabolite ratio (NMR) were performed. Cases and controls differed in mean age, male preponderance, and frequency of alcohol consumption (but not total alcoholic drinks). Univariate analysis revealed similar levels of NNN, 1-HOP, and cotinine between groups but, as reported previously, significantly higher DNA adduct formation in the cases. Multiple regression adjusting for potential confounders showed persistent significant difference in DNA adduct levels between cases and controls [ratio of geometric means, 20.0; 95% CI, 2.7-148.6). Our cohort of smokers with HNSCC demonstrates higher levels of TSNA-derived oral DNA damage in the setting of similar exposure to nicotine and tobacco carcinogens. Among smokers, DNA adduct formation may act as a predictor of eventual development of HNSCC that is independent of carcinogen exposure indicators. Cancer Prev Res; 10(9); 507-13. ©2017 AACRSee related editorial by Johnson and Bauman, p. 489.Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of oral/head and neck squamous cell cancer (HNSCC). We recently reported higher levels of TSNA-associated DNA adducts in the oral cells of smokers with HNSCC as compared with cancer-free smokers. In this study, we further investigated the tobacco constituent exposures in the same smokers to better understand the potential causes for the elevated oral DNA damage in smokers with HNSCC. Subjects included cigarette smokers with HNSCC (cases, n = 30) and cancer-free smokers (controls, n = 35). At recruitment, tobacco/alcohol use questionnaires were completed, and urine and oral cell samples were obtained. Analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and N'-Nitrosonornicotine (NNN; TSNA biomarkers), 1-hydroxypyrene (1-HOP, a PAH), cotinine, 3'-hydroxycotinine, and the nicotine metabolite ratio (NMR) were performed. Cases and controls differed in mean age, male preponderance, and frequency of alcohol consumption (but not total alcoholic drinks). Univariate analysis revealed similar levels of NNN, 1-HOP, and cotinine between groups but, as reported previously, significantly higher DNA adduct formation in the cases. Multiple regression adjusting for potential confounders showed persistent significant difference in DNA adduct levels between cases and controls [ratio of geometric means, 20.0; 95% CI, 2.7-148.6). Our cohort of smokers with HNSCC demonstrates higher levels of TSNA-derived oral DNA damage in the setting of similar exposure to nicotine and tobacco carcinogens. Among smokers, DNA adduct formation may act as a predictor of eventual development of HNSCC that is independent of carcinogen exposure indicators. Cancer Prev Res; 10(9); 507-13. ©2017 AACRSee related editorial by Johnson and Bauman, p. 489.
Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of oral/head and neck squamous cell cancer (HNSCC). We recently reported higher levels of TSNA-associated DNA adducts in the oral cells of smokers with HNSCC as compared with cancer-free smokers. In this study, we further investigated the tobacco constituent exposures in the same smokers to better understand the potential causes for the elevated oral DNA damage in smokers with HNSCC. Subjects included cigarette smokers with HNSCC (cases, = 30) and cancer-free smokers (controls, = 35). At recruitment, tobacco/alcohol use questionnaires were completed, and urine and oral cell samples were obtained. Analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and '-Nitrosonornicotine (NNN; TSNA biomarkers), 1-hydroxypyrene (1-HOP, a PAH), cotinine, 3'-hydroxycotinine, and the nicotine metabolite ratio (NMR) were performed. Cases and controls differed in mean age, male preponderance, and frequency of alcohol consumption (but not total alcoholic drinks). Univariate analysis revealed similar levels of NNN, 1-HOP, and cotinine between groups but, as reported previously, significantly higher DNA adduct formation in the cases. Multiple regression adjusting for potential confounders showed persistent significant difference in DNA adduct levels between cases and controls [ratio of geometric means, 20.0; 95% CI, 2.7-148.6). Our cohort of smokers with HNSCC demonstrates higher levels of TSNA-derived oral DNA damage in the setting of similar exposure to nicotine and tobacco carcinogens. Among smokers, DNA adduct formation may act as a predictor of eventual development of HNSCC that is independent of carcinogen exposure indicators. .
Author Lindgren, Bruce
Carmella, Steven G.
Ruszczak, Chris
Hecht, Stephen S.
Ma, Bin
Hatsukami, Dorothy K.
Stepanov, Irina
Khariwala, Samir S.
AuthorAffiliation 1 Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota
3 Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota
2 Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
4 Environmental Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota
AuthorAffiliation_xml – name: 2 Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
– name: 1 Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota
– name: 4 Environmental Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota
– name: 3 Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota
Author_xml – sequence: 1
  givenname: Samir S.
  surname: Khariwala
  fullname: Khariwala, Samir S.
– sequence: 2
  givenname: Bin
  surname: Ma
  fullname: Ma, Bin
– sequence: 3
  givenname: Chris
  surname: Ruszczak
  fullname: Ruszczak, Chris
– sequence: 4
  givenname: Steven G.
  surname: Carmella
  fullname: Carmella, Steven G.
– sequence: 5
  givenname: Bruce
  surname: Lindgren
  fullname: Lindgren, Bruce
– sequence: 6
  givenname: Dorothy K.
  surname: Hatsukami
  fullname: Hatsukami, Dorothy K.
– sequence: 7
  givenname: Stephen S.
  surname: Hecht
  fullname: Hecht, Stephen S.
– sequence: 8
  givenname: Irina
  surname: Stepanov
  fullname: Stepanov, Irina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28679497$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1uEzEUhS1URH_gFSov2UxrOx57LCGkaFJIpKitSllbHs9NajJjB3sSiR0PwI435EnwqGkFbNjYlu4537nyOUVHPnhA6JySC0rL6pIqTgrBiLyop7d3BZUFoZy8QCeHAS2Pnt9EHqPTlL4QIljFJq_QMauEVFzJE_Rj7tYPeAl76HBY4fvQGGsDrk20zoc1-F_ff84guj20eHY9xTPTmzVg5_FNNB2uoesSXiRsPF74FraQDz_g2wits0OII3RUXs7BtFnV4muwm8z3FiK-c2kzsj71YQMxvUYvV6ZL8OZwn6HPH67u63mxvPm4qKfLwnLKh0JKaQSzTIFVpFTcciEZEWTFKmKJpapqrSCNnDBmiLACTNMQycCySaUM4ZMz9P6Ru901PbQ2b5xX1NvoehO_6WCc_nvi3YNeh70uJWVcsQx4ewDE8HUHadC9Szb_hfEQdklTRYUkqmQqS8__zHoOeaogC949CmwMKUVYaesGM7gwRrtOU6LHxvVYph7L1GPjmko9Np7t4h_7U8J_jL8BI9WwBA
CitedBy_id crossref_primary_10_1021_acs_chemrestox_2c00393
crossref_primary_10_1038_s41568_021_00423_4
crossref_primary_10_3390_curroncol29020069
crossref_primary_10_1016_j_cancergen_2021_05_011
crossref_primary_10_1093_carcin_bgab113
crossref_primary_10_2174_2212796816666211223105911
crossref_primary_10_1016_j_bjorl_2024_101534
crossref_primary_10_1021_acs_chemrestox_0c00223
crossref_primary_10_1158_1055_9965_EPI_19_1356
crossref_primary_10_1007_s11274_022_03461_8
crossref_primary_10_1371_journal_pone_0233111
crossref_primary_10_1158_1940_6207_CAPR_20_0096
crossref_primary_10_1590_1807_3107bor_2023_vol37_0008
crossref_primary_10_3390_ijms23147889
crossref_primary_10_1016_j_niox_2018_06_005
crossref_primary_10_1007_s00204_018_2252_6
crossref_primary_10_1016_j_yamp_2023_08_005
crossref_primary_10_1002_ijc_32823
crossref_primary_10_3390_cancers13205206
crossref_primary_10_1158_1940_6207_CAPR_21_0633
crossref_primary_10_1371_journal_pone_0243084
crossref_primary_10_1002_lio2_204
crossref_primary_10_1158_1940_6207_CAPR_19_0459
crossref_primary_10_1002_lio2_516
crossref_primary_10_1093_carcin_bgac058
crossref_primary_10_1007_s10238_020_00611_w
crossref_primary_10_3390_ijms24032760
crossref_primary_10_3390_biomedicines12030696
crossref_primary_10_1159_000502651
crossref_primary_10_1021_acs_chemrestox_9b00257
crossref_primary_10_1098_rsos_230975
Cites_doi 10.1370/afm.64
10.1093/carcin/9.1.161
10.1021/tx400121n
10.1158/1055-9965.EPI-08-0718
10.1158/1055-9965.1261.13.7
10.1021/acs.accounts.5b00472
10.1016/j.clpt.2004.02.011
10.1111/acel.12019
10.1021/acs.chemrestox.6b00254
10.1021/tx300282k
10.1002/lary.25290
10.1016/0921-8734(94)90010-8
10.1007/s00216-008-2566-y
10.1016/j.jchromb.2015.10.012
10.1021/tx100391z
10.1159/000330807
10.1002/hed.23085
10.1002/ijc.27816
10.1158/0008-5472.CAN-08-4330
10.1016/j.tox.2007.01.016
10.1021/tx00021a017
10.1021/tx980005y
10.1080/1462220031000158717
10.1021/tx0497696
10.3109/01902149809087376
10.1021/tx034003b
10.1080/03014469100001702
10.1093/carcin/bgr125
10.1016/j.tox.2007.12.021
10.1002/ijc.28575
10.1158/0008-5472.CAN-09-1571
10.1016/S1383-5742(00)00047-8
10.1371/journal.pone.0035505
10.1093/carcin/bgt162
ContentType Journal Article
Copyright 2017 American Association for Cancer Research.
Copyright_xml – notice: 2017 American Association for Cancer Research.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1158/1940-6207.CAPR-17-0140
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1940-6215
EndPage 513
ExternalDocumentID PMC5712492
28679497
10_1158_1940_6207_CAPR_17_0140
Genre Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P30 CA077598
– fundername: NIDCR NIH HHS
  grantid: K23 DE023572
– fundername: NCATS NIH HHS
  grantid: UL1 TR002494
– fundername: NCI NIH HHS
  grantid: R01 CA180880
GroupedDBID ---
29B
2FS
34G
39C
53G
5GY
5RE
5VS
AAYXX
ADBBV
ADCOW
AENEX
AFHIN
AFUMD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
EBS
EJD
F5P
H13
KQ8
OK1
P2P
RCR
RHI
W8F
.55
CGR
CUY
CVF
ECM
EIF
NPM
X7M
7X8
5PM
ID FETCH-LOGICAL-c414t-777a62c29ec90594c4672060f280c0c198dc60b7322a06c6eabb072ec2389a043
ISSN 1940-6207
1940-6215
IngestDate Thu Aug 21 18:25:41 EDT 2025
Thu Sep 04 15:53:54 EDT 2025
Thu Apr 03 07:09:38 EDT 2025
Tue Jul 01 01:56:23 EDT 2025
Thu Apr 24 23:01:37 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License 2017 American Association for Cancer Research.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c414t-777a62c29ec90594c4672060f280c0c198dc60b7322a06c6eabb072ec2389a043
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://cancerpreventionresearch.aacrjournals.org/content/canprevres/10/9/507.full.pdf
PMID 28679497
PQID 1916709529
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5712492
proquest_miscellaneous_1916709529
pubmed_primary_28679497
crossref_citationtrail_10_1158_1940_6207_CAPR_17_0140
crossref_primary_10_1158_1940_6207_CAPR_17_0140
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-09-01
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer prevention research (Philadelphia, Pa.)
PublicationTitleAlternate Cancer Prev Res (Phila)
PublicationYear 2017
References Stepanov (2022060815341509500_bib6) 2014; 134
Wong (2022060815341509500_bib35) 2005; 18
Yuan (2022060815341509500_bib3) 2011; 32
Stepanov (2022060815341509500_bib19) 2013; 26
Mayer (2022060815341509500_bib38) 1991; 18
Hochalter (2022060815341509500_bib24) 2011; 24
Goukassian (2022060815341509500_bib40) 2000; 14
Hecht (2022060815341509500_bib26) 1999; 8
Saba (2022060815341509500_bib37) 2011; 81
Hecht (2022060815341509500_bib9) 2012; 131
Holzle (2022060815341509500_bib16) 2007; 232
Khariwala (2022060815341509500_bib1) 2013; 35
Carmella (2022060815341509500_bib21) 2013; 26
Balbo (2022060815341509500_bib32) 2013; 34
Ma (2022060815341509500_bib20) 2016; 29
Hecht (2022060815341509500_bib25) 1999; 59
Foiles (2022060815341509500_bib17) 1991; 4
Nath (2022060815341509500_bib28) 1998; 58
Benowitz (2022060815341509500_bib30) 2003; 5
Garm (2022060815341509500_bib39) 2013; 12
Stone (2022060815341509500_bib42) 1995; 55
Carmella (2022060815341509500_bib23) 2004; 13
Park (2022060815341509500_bib5) 2004; 2
Seo (2022060815341509500_bib7) 2000; 463
Hecht (2022060815341509500_bib14) 1998; 11
Jin (2022060815341509500_bib36) 2012; 7
International Agency for Research on Cancer (2022060815341509500_bib33) 2007
Stepanov (2022060815341509500_bib13) 2013; 26
Heppel (2022060815341509500_bib15) 2009; 393
Kushida (2022060815341509500_bib34) 2000; 21
Church (2022060815341509500_bib2) 2009; 18
Dempsey (2022060815341509500_bib31) 2004; 76
Yuan (2022060815341509500_bib4) 2009; 69
King (2022060815341509500_bib41) 1994; 316
Nesnow (2022060815341509500_bib8) 1998; 24
Schlobe (2022060815341509500_bib18) 2008; 245
Hecht (2022060815341509500_bib11) 1988; 9
Hecht (2022060815341509500_bib10) 2016; 49
Wang (2022060815341509500_bib12) 2003; 16
Khariwala (2022060815341509500_bib29) 2015; 125
Wang (2022060815341509500_bib27) 2009; 69
Kotandeniya (2022060815341509500_bib22) 2015; 1007
28821544 - Cancer Prev Res (Phila). 2017 Sep;10(9):489-490. doi: 10.1158/1940-6207.CAPR-17-0197
References_xml – volume: 2
  start-page: 170
  year: 2004
  ident: 2022060815341509500_bib5
  article-title: Does enhancing partner support and interaction improve smoking cessation? A meta-analysis
  publication-title: Ann Fam Med
  doi: 10.1370/afm.64
– volume: 9
  start-page: 161
  year: 1988
  ident: 2022060815341509500_bib11
  article-title: Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/9.1.161
– volume: 26
  start-page: 1209
  year: 2013
  ident: 2022060815341509500_bib21
  article-title: High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx400121n
– volume: 18
  start-page: 260
  year: 2009
  ident: 2022060815341509500_bib2
  article-title: A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-08-0718
– volume: 13
  start-page: 1261
  year: 2004
  ident: 2022060815341509500_bib23
  article-title: Improved method for determination of 1-hydroxypyrene in human urine
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.1261.13.7
– volume: 49
  start-page: 106
  year: 2016
  ident: 2022060815341509500_bib10
  article-title: Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines
  publication-title: Accounts Chem Res
  doi: 10.1021/acs.accounts.5b00472
– volume: 76
  start-page: 64
  year: 2004
  ident: 2022060815341509500_bib31
  article-title: Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity
  publication-title: Clin Pharmacol Ther
  doi: 10.1016/j.clpt.2004.02.011
– volume: 55
  start-page: 1267
  year: 1995
  ident: 2022060815341509500_bib42
  article-title: Development of a human biomonitoring assay using buccal mucosa: comparison of smoking-related DNA adducts in mucosa versus biopsies
  publication-title: Cancer Res
– volume: 12
  start-page: 58
  year: 2013
  ident: 2022060815341509500_bib39
  article-title: Age and gender effects on DNA strand break repair in peripheral blood mononuclear cells
  publication-title: Aging Cell
  doi: 10.1111/acel.12019
– volume: 29
  start-page: 1849
  year: 2016
  ident: 2022060815341509500_bib20
  article-title: Optimized liquid chromatography nanoelectrospray-high-resolution tandem mass spectrometry method for the analysis of 4-Hydroxy-1-(3-pyridyl)-1-butanone-Releasing DNA adducts in human oral cells
  publication-title: Chem Res Toxicol
  doi: 10.1021/acs.chemrestox.6b00254
– volume: 26
  start-page: 37
  year: 2013
  ident: 2022060815341509500_bib19
  article-title: Analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing DNA adducts in human exfoliated oral mucosa cells by liquid chromatography-electrospray ionization-tandem mass spectrometry
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx300282k
– volume: 125
  start-page: 1844
  year: 2015
  ident: 2022060815341509500_bib29
  article-title: Self-reported tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer
  publication-title: Laryngoscope
  doi: 10.1002/lary.25290
– volume: 316
  start-page: 79
  year: 1994
  ident: 2022060815341509500_bib41
  article-title: An investigation of mutation as a function of age in humans
  publication-title: Mutat Res
  doi: 10.1016/0921-8734(94)90010-8
– volume: 14
  start-page: 1325
  year: 2000
  ident: 2022060815341509500_bib40
  article-title: Mechanisms and implications of the age-associated decrease in DNA repair capacity
  publication-title: FASEB J
– volume: 393
  start-page: 1525
  year: 2009
  ident: 2022060815341509500_bib15
  article-title: Ultrasensitive method for the determination of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts by gas chromatography-high resolution mass spectrometry in mucosal biopsies of the lower esophagus
  publication-title: Anal Bioanal Chem
  doi: 10.1007/s00216-008-2566-y
– volume: 1007
  start-page: 121
  year: 2015
  ident: 2022060815341509500_bib22
  article-title: Combined analysis of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users
  publication-title: J Chromatogr B Analyt Technol Biomed Life Sci
  doi: 10.1016/j.jchromb.2015.10.012
– volume: 24
  start-page: 262
  year: 2011
  ident: 2022060815341509500_bib24
  article-title: Quantitation of a minor enantiomer of phenanthrene tetraol in human urine: correlations with levels of overall phenanthrene tetraol, benzo[a]pyrene tetraol, and 1-hydroxypyrene
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx100391z
– volume: 81
  start-page: 12
  year: 2011
  ident: 2022060815341509500_bib37
  article-title: Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis
  publication-title: Oncology
  doi: 10.1159/000330807
– volume: 35
  start-page: 1096
  year: 2013
  ident: 2022060815341509500_bib1
  article-title: Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: a matched control study
  publication-title: Head Neck
  doi: 10.1002/hed.23085
– volume: 131
  start-page: 2724
  year: 2012
  ident: 2022060815341509500_bib9
  article-title: Lung carcinogenesis by tobacco smoke
  publication-title: Int J Cancer
  doi: 10.1002/ijc.27816
– volume: 69
  start-page: 2990
  year: 2009
  ident: 2022060815341509500_bib4
  article-title: Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-4330
– volume: 232
  start-page: 277
  year: 2007
  ident: 2022060815341509500_bib16
  article-title: Mass spectrometric analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in human lung
  publication-title: Toxicology
  doi: 10.1016/j.tox.2007.01.016
– volume: 4
  start-page: 364
  year: 1991
  ident: 2022060815341509500_bib17
  article-title: Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx00021a017
– volume: 59
  start-page: 590
  year: 1999
  ident: 2022060815341509500_bib25
  article-title: Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation
  publication-title: Cancer Res
– volume: 11
  start-page: 559
  year: 1998
  ident: 2022060815341509500_bib14
  article-title: Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx980005y
– volume: 8
  start-page: 907
  year: 1999
  ident: 2022060815341509500_bib26
  article-title: Effects of watercress consumption on urinary metabolites of nicotine in smokers
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 5
  start-page: 621
  year: 2003
  ident: 2022060815341509500_bib30
  article-title: Nicotine metabolite ratio as a predictor of cigarette consumption
  publication-title: Nicotine Tob Res
  doi: 10.1080/1462220031000158717
– start-page: 57
  year: 2007
  ident: 2022060815341509500_bib33
  article-title: Smokeless tobacco and tobacco-specific nitrosamines
– volume: 26
  start-page: 37
  year: 2013
  ident: 2022060815341509500_bib13
  article-title: Analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing DNA adducts in human exfoliated oral mucosa cells by liquid chromatography-electrospray ionization-tandem mass spectrometry
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx300282k
– volume: 58
  start-page: 581
  year: 1998
  ident: 2022060815341509500_bib28
  article-title: 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue
  publication-title: Cancer Res
– volume: 18
  start-page: 61
  year: 2005
  ident: 2022060815341509500_bib35
  article-title: Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx0497696
– volume: 24
  start-page: 395
  year: 1998
  ident: 2022060815341509500_bib8
  article-title: Mechanistic relationships between DNA adducts, oncogene mutations, and lung tumorigenesis in strain A mice
  publication-title: Exp Lung Res
  doi: 10.3109/01902149809087376
– volume: 16
  start-page: 616
  year: 2003
  ident: 2022060815341509500_bib12
  article-title: Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx034003b
– volume: 18
  start-page: 405
  year: 1991
  ident: 2022060815341509500_bib38
  article-title: Gender differences in age-related decline in DNA double-strand break damage and repair in lymphocytes
  publication-title: Ann Hum Biol
  doi: 10.1080/03014469100001702
– volume: 32
  start-page: 1366
  year: 2011
  ident: 2022060815341509500_bib3
  article-title: Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgr125
– volume: 245
  start-page: 154
  year: 2008
  ident: 2022060815341509500_bib18
  article-title: 4-Hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in lung, lower esophagus and cardia of sudden death victims
  publication-title: Toxicology
  doi: 10.1016/j.tox.2007.12.021
– volume: 134
  start-page: 2278
  year: 2014
  ident: 2022060815341509500_bib6
  article-title: Tobacco-specific N-nitrosamine exposures and cancer risk in the shanghai cohort study: remarkable coherence with rat tumor sites
  publication-title: Int J Cancer
  doi: 10.1002/ijc.28575
– volume: 69
  start-page: 7170
  year: 2009
  ident: 2022060815341509500_bib27
  article-title: Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-1571
– volume: 21
  start-page: 1227
  year: 2000
  ident: 2022060815341509500_bib34
  article-title: Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase
  publication-title: Carcinogenesis
– volume: 463
  start-page: 215
  year: 2000
  ident: 2022060815341509500_bib7
  article-title: Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens
  publication-title: Mutat Res
  doi: 10.1016/S1383-5742(00)00047-8
– volume: 7
  start-page: e35505
  year: 2012
  ident: 2022060815341509500_bib36
  article-title: Ethanol-mediated regulation of cytochrome P450 2A6 expression in monocytes: role of oxidative stress-mediated PKC/MEK/Nrf2 pathway
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0035505
– volume: 34
  start-page: 2178
  year: 2013
  ident: 2022060815341509500_bib32
  article-title: (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgt162
– reference: 28821544 - Cancer Prev Res (Phila). 2017 Sep;10(9):489-490. doi: 10.1158/1940-6207.CAPR-17-0197
SSID ssj0062823
Score 2.3325317
Snippet Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 507
SubjectTerms Adult
Aged
Alcohol Drinking - adverse effects
Biomarkers, Tumor - urine
Carcinogens - toxicity
Case-Control Studies
Cohort Studies
DNA Adducts - metabolism
DNA Adducts - urine
DNA Damage
Female
Head and Neck Neoplasms - chemically induced
Head and Neck Neoplasms - urine
Humans
Male
Middle Aged
Mouth - cytology
Mouth - metabolism
Nitrosamines - toxicity
Nitrosamines - urine
Polycyclic Aromatic Hydrocarbons - toxicity
Polycyclic Aromatic Hydrocarbons - urine
Risk Factors
Smokers - statistics & numerical data
Smoking - adverse effects
Tobacco Products - adverse effects
Title High Level of Tobacco Carcinogen–Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers
URI https://www.ncbi.nlm.nih.gov/pubmed/28679497
https://www.proquest.com/docview/1916709529
https://pubmed.ncbi.nlm.nih.gov/PMC5712492
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bjtowELXoVqr6UvW-9CZX6hsKOCbXR8S2Yrtdut2y0r5FjuOICEgQl1biE_pD_b3OxCaEZateXiKUOJOIObFn7DPHhLwTXqyCVMVWaovEckQsrYAnGMglXsDCgEmOxcnnQ29w5Xy8dq8bjZ811tJ6Fbfl5ta6kv_xKpwDv2KV7D94tjIKJ-A3-BeO4GE4_pWPkaTR-oS0H4z5RvBpSlkgh0NmeQF3WSfwFt8gpDwZ9sC_M-TnZHnrMxbl99V0umydokQzdBLbvXBXyMlIMpzJR5PYEl5vAEAoVxmGSk7APgBl0bpEUjpY-zorJoZGX5M8wBZzIw9VYMmMmV6BgBbncFCccj7WRN0L0a7NR5yNIXv_LqZCz1fPskWrNm1ewjHbVa-tlxu5EZNKJmG3pLKYIa_LENngNcwmYmaCAwbNLYMLxifdKYdYosB12WfVa7MaOsNaF-zqXXQPhwYXyx2MLea3-72LSwufZmu9qBpe5rMSMBzFCB1NH74hyr29dIfc5ZCf4J4hZ1-q5SsP8tiuKUeHx3ZufyjqUBsz-0HRQaZzk7Bbi4BGD8kDk7rQnsbhI9JQ-WNy79yQM56QHwhHWsKRFik1cKSHcKQAR6rhSLOcIshoCUd6uqQipzU40gqOaBJbdhCM0CqhCEaqoUYRjGjLgPEpufrwftQfWGarD0s6trOCrsEXHpc8VDJEBSEJ4zdnHks59BZM2mGQSI_FPgw_gnnSUyKOmc-VhIgzFMzpPiNHeZGrY0K7UvhhKLmXprGTeAIlGVXi2ZBKcgZmmsTd_teRNDr4uB3LNCrzYTeI0F0RuitCd0W2H6G7mqRT3TfXSjB_vOPt1pURdNq4EidyVayX0N5G3USXh03yXLu2srnFRJP4e06vGqAg_P6VPBuXwvCuj1vJ8xe_tfmS3N99Ya_I0WqxVq8hqF7Fb0oA_wIltceQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+Level+of+Tobacco+Carcinogen-Derived+DNA+Damage+in+Oral+Cells+Is+an+Independent+Predictor+of+Oral%2FHead+and+Neck+Cancer+Risk+in+Smokers&rft.jtitle=Cancer+prevention+research+%28Philadelphia%2C+Pa.%29&rft.au=Khariwala%2C+Samir+S&rft.au=Ma%2C+Bin&rft.au=Ruszczak%2C+Chris&rft.au=Carmella%2C+Steven+G&rft.date=2017-09-01&rft.eissn=1940-6215&rft.volume=10&rft.issue=9&rft.spage=507&rft_id=info:doi/10.1158%2F1940-6207.CAPR-17-0140&rft_id=info%3Apmid%2F28679497&rft.externalDocID=28679497
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1940-6207&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1940-6207&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1940-6207&client=summon